The purpose of this study is to compare the use of hormone therapy and radiation therapy (usual treatment) to the use of apalutamide and abiraterone acetate with prednisone plus the usual treatment.
Learn more about the NRG-GU008 trial or call the Reading Hospital Cancer Research Office at 484-628-8193.
